[
  {
    "ts": null,
    "headline": "Stock Market Today: Nasdaq Surges On Tech Spike; These Defense Stocks Fall Amid Ukraine Progress (Live Coverage)",
    "summary": "The Dow Jones index and the Nasdaq rose on the stock market today, with Tesla and Alphabet among AI stocks jumping. Health stocks tested entries.",
    "url": "https://finnhub.io/api/news?id=c607618f2af4a40052d36008baadd6f292ee13e988c796371e291e14f35248ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764011020,
      "headline": "Stock Market Today: Nasdaq Surges On Tech Spike; These Defense Stocks Fall Amid Ukraine Progress (Live Coverage)",
      "id": 137592601,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Dow Jones index and the Nasdaq rose on the stock market today, with Tesla and Alphabet among AI stocks jumping. Health stocks tested entries.",
      "url": "https://finnhub.io/api/news?id=c607618f2af4a40052d36008baadd6f292ee13e988c796371e291e14f35248ef"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow, Nasdaq Up As Alphabet, Tesla Jump; These Health Plays Test Entries (Live Coverage)",
    "summary": "The Dow Jones index and the Nasdaq rose on the stock market today, with Tesla and Alphabet among AI stocks jumping. Health stock tested entries.",
    "url": "https://finnhub.io/api/news?id=1be78d575ac99d4ec0f939f4d78fac9c8abceae69847c82c79933cc0bd0f6443",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764006136,
      "headline": "Stock Market Today: Dow, Nasdaq Up As Alphabet, Tesla Jump; These Health Plays Test Entries (Live Coverage)",
      "id": 137591212,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Dow Jones index and the Nasdaq rose on the stock market today, with Tesla and Alphabet among AI stocks jumping. Health stock tested entries.",
      "url": "https://finnhub.io/api/news?id=1be78d575ac99d4ec0f939f4d78fac9c8abceae69847c82c79933cc0bd0f6443"
    }
  },
  {
    "ts": null,
    "headline": "Why Merck (MRK) Stock Is Trading Up Today",
    "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to \"Overweight\" from \"Equal-Weight,\" citing confidence in the company's future.",
    "url": "https://finnhub.io/api/news?id=b7c631b53ad74c1fea8b2850ec32a5a9ae68b913847a3e9d70c179fe69e56e7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764006053,
      "headline": "Why Merck (MRK) Stock Is Trading Up Today",
      "id": 137592737,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to \"Overweight\" from \"Equal-Weight,\" citing confidence in the company's future.",
      "url": "https://finnhub.io/api/news?id=b7c631b53ad74c1fea8b2850ec32a5a9ae68b913847a3e9d70c179fe69e56e7c"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Upgrades Merck (MRK)",
    "summary": "Wells Fargo Upgrades Merck (MRK)",
    "url": "https://finnhub.io/api/news?id=fc6d800a9054991035bd5c73ac00f7a883d4de04f4a79f892047957250df21e6",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764003350,
      "headline": "Wells Fargo Upgrades Merck (MRK)",
      "id": 137591097,
      "image": "",
      "related": "MRK",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=fc6d800a9054991035bd5c73ac00f7a883d4de04f4a79f892047957250df21e6"
    }
  },
  {
    "ts": null,
    "headline": "FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer",
    "summary": "Merck gains FDA nod for Keytruda and Keytruda Qlex with Padcev in MIBC, marking the first PD-1 inhibitor plus ADC regimens for this patient group.",
    "url": "https://finnhub.io/api/news?id=98af2cc2f9a873f458c3b28f9971f784da04a2430e2d118d134cbcf96e09fa8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763999400,
      "headline": "FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer",
      "id": 137591453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck gains FDA nod for Keytruda and Keytruda Qlex with Padcev in MIBC, marking the first PD-1 inhibitor plus ADC regimens for this patient group.",
      "url": "https://finnhub.io/api/news?id=98af2cc2f9a873f458c3b28f9971f784da04a2430e2d118d134cbcf96e09fa8e"
    }
  },
  {
    "ts": null,
    "headline": "Urinary Tract Infection Treatment Market Competitor Analysis Report 2025: Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue",
    "summary": "The Urinary Tract Infection (UTI) Treatment Market is projected to grow from US$ 9.13 Billion in 2024 to US$ 11.64 Billion by 2033, at a CAGR of 2.73%. This expansion is driven by rising UTI prevalence, awareness of early diagnosis, and advancements in therapy. Key growth factors include aging populations, rising catheter-associated infections, and a growing female demographic. Innovative treatments like vaccines and probiotics are gaining traction amid antibiotic resistance. North America leads",
    "url": "https://finnhub.io/api/news?id=0f4d448939a18426431f9da10b2fc6771902e05162ea839762bdf290903530c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763998620,
      "headline": "Urinary Tract Infection Treatment Market Competitor Analysis Report 2025: Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue",
      "id": 137591454,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Urinary Tract Infection (UTI) Treatment Market is projected to grow from US$ 9.13 Billion in 2024 to US$ 11.64 Billion by 2033, at a CAGR of 2.73%. This expansion is driven by rising UTI prevalence, awareness of early diagnosis, and advancements in therapy. Key growth factors include aging populations, rising catheter-associated infections, and a growing female demographic. Innovative treatments like vaccines and probiotics are gaining traction amid antibiotic resistance. North America leads",
      "url": "https://finnhub.io/api/news?id=0f4d448939a18426431f9da10b2fc6771902e05162ea839762bdf290903530c5"
    }
  },
  {
    "ts": null,
    "headline": "Merck upgraded at Wells Fargo as analyst sees ‘a future beyond Keytruda’",
    "summary": "Investing.com -- Merck shares received an upgrade at Wells Fargo, with analyst Mohit Bansa lifting the stock to Overweight and raising the price target to $125 per share in a note Monday, saying the firm “can see a future beyond Keytruda” as the company enters a catalyst-heavy stretch.",
    "url": "https://finnhub.io/api/news?id=a0396f9835ec870e6d5801667ef8e8b0be579e029a07f6b28dc946de61483b47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763997987,
      "headline": "Merck upgraded at Wells Fargo as analyst sees ‘a future beyond Keytruda’",
      "id": 137591455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Investing.com -- Merck shares received an upgrade at Wells Fargo, with analyst Mohit Bansa lifting the stock to Overweight and raising the price target to $125 per share in a note Monday, saying the firm “can see a future beyond Keytruda” as the company enters a catalyst-heavy stretch.",
      "url": "https://finnhub.io/api/news?id=a0396f9835ec870e6d5801667ef8e8b0be579e029a07f6b28dc946de61483b47"
    }
  },
  {
    "ts": null,
    "headline": "Booking, Carvana upgraded: Wall Street's top analyst calls",
    "summary": "Booking, Carvana upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=0f5f129f7c998980ac8af86edd2de703660b77cb241f70048c181d6e85e403a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763995260,
      "headline": "Booking, Carvana upgraded: Wall Street's top analyst calls",
      "id": 137591331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Booking, Carvana upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=0f5f129f7c998980ac8af86edd2de703660b77cb241f70048c181d6e85e403a7"
    }
  },
  {
    "ts": null,
    "headline": "Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More",
    "summary": "Pre-Market Stock Futures: The shortened holiday week is here, and the futures are trading higher this morning. Most traders and investors are returning with a severe case of whiplash after the stock market posted some of the wildest swings we have seen this year last week. Skyrocketing after the NVIDIA Corp (NASDAQ: NVDA) earnings and ... Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More",
    "url": "https://finnhub.io/api/news?id=e05b7b56594c0efd8c240bfcc8847e2b42100c49176c2c561dc0375f32c59184",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763994045,
      "headline": "Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More",
      "id": 137591332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Pre-Market Stock Futures: The shortened holiday week is here, and the futures are trading higher this morning. Most traders and investors are returning with a severe case of whiplash after the stock market posted some of the wildest swings we have seen this year last week. Skyrocketing after the NVIDIA Corp (NASDAQ: NVDA) earnings and ... Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More",
      "url": "https://finnhub.io/api/news?id=e05b7b56594c0efd8c240bfcc8847e2b42100c49176c2c561dc0375f32c59184"
    }
  },
  {
    "ts": null,
    "headline": "Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches",
    "summary": "RAHWAY, N.J., November 24, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data across multiple hematologic malignancies will be presented at the American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Fla. from Dec. 6-9. The data shared at the meeting will highlight the company’s ongoing commitment to advancing clinical research in hematology across Merck’s expanding and diverse pipeline of investigational candidates",
    "url": "https://finnhub.io/api/news?id=2232b5799c577b71f3d9d2071e04b67874b72faefb0926862d71a426ee72de28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763984700,
      "headline": "Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches",
      "id": 137589193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., November 24, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data across multiple hematologic malignancies will be presented at the American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Fla. from Dec. 6-9. The data shared at the meeting will highlight the company’s ongoing commitment to advancing clinical research in hematology across Merck’s expanding and diverse pipeline of investigational candidates",
      "url": "https://finnhub.io/api/news?id=2232b5799c577b71f3d9d2071e04b67874b72faefb0926862d71a426ee72de28"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more",
    "summary": "These are the stocks posting the largest moves in the premarket.",
    "url": "https://finnhub.io/api/news?id=0ecfadf9d809ea7cc105e23a02d1d56588f97405fbcb629477fe5a849b98bf60",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763971041,
      "headline": "Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more",
      "id": 137590955,
      "image": "https://image.cnbcfm.com/api/v1/image/108226738-1763385616705-gettyimages-2221165669-INDIA_WEGOVY.jpeg?v=1763385675&w=1920&h=1080",
      "related": "MRK",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in the premarket.",
      "url": "https://finnhub.io/api/news?id=0ecfadf9d809ea7cc105e23a02d1d56588f97405fbcb629477fe5a849b98bf60"
    }
  },
  {
    "ts": null,
    "headline": "Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Merck (NYSE:MRK) and the best and worst performers in the branded pharmaceuticals industry.",
    "url": "https://finnhub.io/api/news?id=64c560afdedbabd5825de3a78095420a5c46edb90f3a334bda81ddfa562a2699",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763955318,
      "headline": "Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks",
      "id": 137589194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Merck (NYSE:MRK) and the best and worst performers in the branded pharmaceuticals industry.",
      "url": "https://finnhub.io/api/news?id=64c560afdedbabd5825de3a78095420a5c46edb90f3a334bda81ddfa562a2699"
    }
  }
]